Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Dr. Margaret Han DuganMember of SA, Commercial & Medical Affairs Advisory Committee and Independent Non-Exec. Director | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 56,94k | 23,90% |
| 2026-05-21 | Dr. Alessandro RivaCo-Chairman of Scientific Advisory Committee & Director | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 56,94k | 23,90% |
| 2026-05-21 | Dr. Corazon Dating SandersIndependent Non-Executive Director and Member of Commercial & Medical Affairs Advis. & SA Committee | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 57,23k | 23,76% |
| 2026-05-22 | Mr. Ranjeev KrishanaMember of Commercial & Medical Affairs Advisory Committee and Independent Lead Director | -2,76k | 65,57k | Verkauf | 23,79 | 71,27k | -3,72% |
| 2026-05-22 | Mr. Michael J. GollerIndependent Non-Executive Director & Member of the Scientific Advisory Committee | -2,74k | 65,42k | Verkauf | 23,85 | 71,28k | -3,71% |
| 2026-05-21 | Mr. Ranjeev KrishanaMember of Commercial & Medical Affairs Advisory Committee and Independent Lead Director | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 74,02k | 17,43% |
| 2026-05-21 | Mr. Michael J. GollerIndependent Non-Executive Director & Member of the Scientific Advisory Committee | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 74,02k | 17,43% |
| 2026-05-20 | Capital Research and Management CompanyUnternehmen | 72,54k | 21,91M | Kauf | 302,13 | 6,54M | 1,12% |
| 2026-05-13 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -332,00 | 39,56k | Derivative Exercise and Sale | 159,03 - 310,72 | 0,00 | - |
| 2026-05-07 | JPMorgan Chase & Co.Unternehmen | 406,08k | 9,85M | Kauf | 24,26 | 23,19k | -106,06% |
| 2026-05-05 | JPMorgan Chase & Co.Unternehmen | -706,53k | 15,88M | Verkauf | 22,47 | 119,23k | -85,56% |
| 2026-04-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -332,00 | 39,85k | Derivative Exercise and Sale | 159,03 - 311,59 | 0,00 | - |
| 2026-03-11 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -341,00 | 36,95k | Derivative Exercise and Sale | 159,03 - 300,00 | 0,00 | - |
| 2026-02-04 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -1,66k | 262,48k | Derivative Exercise and Sale | 159,03 - 350,00 | 0,00 | - |
| 2026-02-03 | JPMorgan Chase & Co.Unternehmen | 1,04M | 27,38M | Kauf | 26,23 | 2,26M | 85,78% |
| 2026-01-15 | JPMorgan Chase & Co.Unternehmen | 35,57k | 938,72k | Kauf | 26,39 | 236,26k | 17,73% |
| 2026-01-15 | JPMorgan Chase & Co.Unternehmen | 1,55M | 40,93M | Kauf | 26,39 | 2,36M | 191,64% |
| 2026-01-15 | JPMorgan Chase & Co.Unternehmen | -191,33k | 5,05M | Verkauf | 26,39 | 2,36M | -7,50% |
| 2026-01-16 | JPMorgan Chase & Co.Unternehmen | 28,69k | 746,29k | Kauf | 26,01 | 253,90k | 12,74% |
| 2026-01-16 | JPMorgan Chase & Co.Unternehmen | -117,00 | 3,04k | Verkauf | 26,01 | 253,90k | -0,05% |
| 2026-01-16 | JPMorgan Chase & Co.Unternehmen | -1,67M | 43,53M | Verkauf | 26,01 | 711,32k | -70,17% |
| 2026-01-14 | JP Morgan Asset ManagementUnternehmen | -3,90k | 103,29k | Verkauf | 26,48 | 55,92k | -6,52% |
| 2026-01-14 | JPMorgan Chase & Co.Unternehmen | 9,25k | 245,09k | Kauf | 26,48 | 202,24k | 4,80% |
| 2026-01-14 | JPMorgan Chase & Co.Unternehmen | -4,89k | 129,46k | Verkauf | 26,48 | 202,24k | -2,36% |
| 2026-01-14 | JPMorgan Chase & Co.Unternehmen | 167,86k | 4,45M | Kauf | 26,48 | 783,04k | 27,29% |
| 2026-01-14 | JPMorgan Chase & Co.Unternehmen | -1,94M | 51,30M | Verkauf | 26,48 | 783,04k | -71,21% |
| 2026-01-08 | JPMorgan Chase & Co.Unternehmen | -546,40k | 0,00 | Other Disposition | - | 769,48k | -41,52% |
| 2026-01-07 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -664,00 | 93,09k | Derivative Exercise and Sale | 159,03 - 331,76 | 0,00 | - |
| 2025-12-31 | Mr. Anthony C. HooperChairman of Commercial & Medical Affairs Advisory Committee and Ind. Non Executive Director | 12,92k | 0,00 | Derivative Exercise and Retained Stock | - | 37,41k | 52,76% |
| 2025-12-19 | JPMorgan Chase & Co.Unternehmen | -140,55k | 0,00 | Other Disposition | - | 798,45k | -14,97% |
| 2025-12-16 | JPMorgan Chase & Co.Unternehmen | -762,99k | 0,00 | Other Disposition | - | 258,01k | -74,73% |
| 2025-12-16 | JPMorgan Chase & Co.Unternehmen | -15,81k | 0,00 | Other Disposition | - | 1,79M | -0,88% |
| 2025-12-15 | JPMorgan Chase & Co.Unternehmen | -598,45k | 0,00 | Other Disposition | - | 1,47M | -28,86% |
| 2025-12-11 | JP Morgan Asset ManagementUnternehmen | -500,00 | 0,00 | Other Disposition | - | -500,00 | - |
| 2025-12-11 | JPMorgan Chase & Co.Unternehmen | -171,98k | 0,00 | Other Disposition | - | 1,04M | -14,20% |
| 2025-12-15 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -100,00k | 30,66M | Automatic Disposition | 300,80 - 314,92 | 0,00 | -100,00% |
| 2025-12-10 | JPMorgan Chase & Co.Unternehmen | -508,02k | 0,00 | Other Disposition | - | 1,40M | -26,65% |
| 2025-12-10 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -664,00 | 86,37k | Derivative Exercise and Sale | 159,03 - 325,00 | 0,00 | - |
| 2025-11-26 | Dr. Corazon Dating SandersIndependent Non-Executive Director and Member of Commercial & Medical Affairs Advis. & SA Committee | -2,63k | 477,76k | Derivative Exercise and Sale | 159,03 - 342,47 | 0,00 | - |
| 2025-11-13 | JPMorgan Chase & Co.Unternehmen | -771,57k | 0,00 | Other Disposition | - | 2,48M | -23,73% |
| 2025-11-17 | Dr. Xiaobin WuInsider | -3,99k | 1,52M | Verkauf | 380,23 - 382,32 | 16,37k | -19,61% |
| 2025-11-12 | Dr. Xiaobin WuInsider | -16,01k | 5,85M | Verkauf | 350,44 - 381,05 | 16,37k | -49,45% |
| 2025-11-12 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -996,00 | 157,07k | Derivative Exercise and Sale | 159,03 - 350,00 | 0,00 | - |
| 2025-11-11 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -1,01M | 0,00 | Other Disposition | - | 51,48M | -1,92% |
| 2025-11-07 | Dr. Xiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | -424,07k | 0,00 | Other Disposition | - | 9,32M | -4,35% |
| 2025-10-21 | JPMorgan Chase & Co.Unternehmen | -9,47k | 0,00 | Other Disposition | - | 1,59M | -0,59% |
| 2025-10-15 | JPMorgan Chase & Co.Unternehmen | -22,95k | 0,00 | Other Disposition | - | 270,26k | -7,83% |
| 2025-10-15 | JPMorgan Chase & Co.Unternehmen | -136,97k | 0,00 | Other Disposition | - | 1,54M | -8,19% |
| 2025-10-14 | JPMorgan Chase & Co.Unternehmen | -97,34k | 0,00 | Other Disposition | - | 271,74k | -26,37% |
| 2025-10-14 | JPMorgan Chase & Co.Unternehmen | -1,60k | 0,00 | Other Disposition | - | 1,54M | -0,10% |
| 2025-10-13 | JPMorgan Chase & Co.Unternehmen | -615,48k | 0,00 | Other Disposition | - | 1,52M | -28,79% |
| 2025-10-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -9,56k | 1,33M | Derivative Exercise and Sale | 159,03 - 351,12 | - | - |
| 2025-10-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -1,11k | 389,20k | Automatic Disposition | 350,00 | 0,00 | -100,00% |
| 2025-09-22 | JPMorgan Chase & Co.Unternehmen | -35,06k | 0,00 | Other Disposition | - | 277,27k | -11,23% |
| 2025-09-22 | JPMorgan Chase & Co.Unternehmen | -399,98k | 0,00 | Other Disposition | - | 2,06M | -16,24% |
| 2025-09-17 | JPMorgan Chase & Co.Unternehmen | -24,28k | 0,00 | Other Disposition | - | 274,35k | -8,13% |
| 2025-09-17 | JPMorgan Chase & Co.Unternehmen | -346,93k | 0,00 | Other Disposition | - | 1,95M | -15,10% |
| 2025-09-16 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -27,80k | 9,06M | Automatic Disposition | 324,12 - 327,78 | 0,00 | -100,00% |
| 2025-09-12 | JPMorgan Chase & Co.Unternehmen | -671,57k | 0,00 | Other Disposition | - | 1,75M | -27,70% |
| 2025-09-10 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -8,89k | 1,14M | Derivative Exercise and Sale | 159,03 - 327,93 | 0,00 | - |
| 2025-09-10 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -1,11k | 361,40k | Automatic Disposition | 325,00 | 0,00 | -100,00% |
| 2025-09-09 | JPMorgan Chase & Co.Unternehmen | -208,12k | 0,00 | Other Disposition | - | 1,73M | -10,76% |
| 2025-09-09 | Dr. Xiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | -148,10k | 0,00 | Other Disposition | - | 9,74M | -1,50% |
| 2025-09-09 | Mr. Wang LaiPresident and Global Head of Research & Development | -5,00k | 1,75M | Automatic Disposition | 350,06 | 0,00 | -100,00% |
| 2025-09-09 | Capital Research and Management CompanyUnternehmen | 67,88k | 3,03M | Kauf | 44,70 | 5,32M | 1,29% |
| 2025-09-05 | Dr. Corazon Dating SandersIndependent Non-Executive Director and Member of Commercial & Medical Affairs Advis. & SA Committee | -2,67k | 483,22k | Derivative Exercise and Sale | 155,68 - 337,00 | 0,00 | - |
| 2025-09-02 | Mr. Titus B. BallVP & CAO | -122,00 | 39,86k | Verkauf | 326,76 | 0,00 | -100,00% |
| 2025-08-13 | Dr. Xiaobin WuInsider | -89,79k | 12,91M | Derivative Exercise and Sale | 155,68 - 308,03 | 16,37k | - |
| 2025-08-13 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -8,23k | 1,01M | Derivative Exercise and Sale | 159,03 - 301,00 | 0,00 | - |
| 2025-08-13 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -2,78k | 836,57k | Automatic Disposition | 300,00 - 301,00 | 0,00 | -100,00% |
| 2025-08-11 | Capital Research and Management CompanyUnternehmen | -55,08k | 15,89M | Verkauf | 288,52 | 5,21M | -1,05% |
| 2025-08-01 | Mr. Aaron RosenbergCFO | -1,19k | 345,66k | Verkauf | 290,47 | 0,00 | -100,00% |
| 2025-07-29 | Mr. Wang LaiPresident and Global Head of Research & Development | -4,30k | 1,30M | Automatic Disposition | 302,00 - 305,00 | 0,00 | -100,00% |
| 2025-07-30 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -920,00 | 280,23k | Verkauf | 304,60 | 0,00 | -100,00% |
| 2025-07-18 | Mr. Wang LaiPresident and Global Head of Research & Development | -700,00 | 210,00k | Automatic Disposition | 300,00 | 0,00 | -100,00% |
| 2025-07-17 | JPMorgan Chase & Co.Unternehmen | -794,20k | 0,00 | Other Disposition | - | 1,29M | -38,16% |
| 2025-07-09 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -27,80k | 7,04M | Automatic Disposition | 252,23 - 254,83 | 0,00 | -100,00% |
| 2025-06-23 | JPMorgan Chase & Co.Unternehmen | -1,45M | 0,00 | Other Disposition | - | 1,30M | -52,81% |
| 2025-06-23 | Mr. Wang LaiPresident and Global Head of Research & Development | -1,03k | 267,28k | Verkauf | 260,00 | 0,00 | -100,00% |
| 2025-06-23 | Dr. Xiaobin WuInsider | -1,36k | 354,38k | Verkauf | 260,00 | 16,37k | -7,69% |
| 2025-06-24 | Dr. Xiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | -2,01k | 532,87k | Automatic Disposition | 263,50 - 267,81 | 0,00 | -100,00% |
| 2025-06-23 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -3,17k | 830,36k | Verkauf | 261,57 - 262,90 | 0,00 | -100,00% |
| 2025-06-16 | JPMorgan Chase & Co.Unternehmen | -76,65k | 0,00 | Other Disposition | - | 418,02k | -15,49% |
| 2025-06-16 | JPMorgan Chase & Co.Unternehmen | -1,05M | 0,00 | Other Disposition | - | 1,96M | -34,91% |
| 2025-06-16 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -422,00 | 112,46k | Verkauf | 266,50 | 0,00 | -100,00% |
| 2025-06-16 | Mr. Wang LaiPresident and Global Head of Research & Development | -1,65k | 431,70k | Verkauf | 251,37 - 266,40 | 0,00 | -100,00% |
| 2025-06-16 | Dr. Xiaobin WuInsider | -2,17k | 567,74k | Verkauf | 250,87 - 266,22 | 16,37k | -11,72% |
| 2025-06-17 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -1,46k | 374,47k | Verkauf | 256,49 | 0,00 | -100,00% |
| 2025-06-16 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -3,68k | 979,05k | Verkauf | 266,05 | 0,00 | -100,00% |
| 2025-06-13 | JPMorgan Chase & Co.Unternehmen | -77,70k | 0,00 | Other Disposition | - | 1,87M | -3,98% |
| 2025-06-12 | JP Morgan Asset ManagementUnternehmen | 91,00 | 1,94k | Kauf | 21,37 | 254,14k | 0,04% |
| 2025-06-12 | JPMorgan Chase & Co.Unternehmen | 624,00 | 13,33k | Kauf | 21,37 | 275,64k | 0,23% |
| 2025-06-12 | JPMorgan Chase & Co.Unternehmen | -3,71k | 79,16k | Verkauf | 21,37 | 275,64k | -1,33% |
| 2025-06-12 | JPMorgan Chase & Co.Unternehmen | -19,14k | 0,00 | Other Disposition | - | 275,64k | -6,49% |
| 2025-06-12 | JPMorgan Chase & Co.Unternehmen | 1,11M | 23,75M | Kauf | 21,37 | 1,27M | 694,17% |
| 2025-06-12 | JPMorgan Chase & Co.Unternehmen | -991,15k | 0,00 | Other Disposition | - | 1,27M | -43,80% |
| 2025-06-11 | JPMorgan Chase & Co.Unternehmen | -111,66k | 0,00 | Other Disposition | - | 297,86k | -27,27% |
| 2025-06-10 | JP Morgan Asset ManagementUnternehmen | 535,00 | 10,92k | Kauf | 20,40 | 254,05k | 0,21% |
| 2025-06-10 | JPMorgan Chase & Co.Unternehmen | 50,87k | 1,04M | Kauf | 20,40 | 285,41k | 21,69% |
| 2025-06-10 | JPMorgan Chase & Co.Unternehmen | -32,29k | 658,78k | Verkauf | 20,40 | 285,41k | -10,16% |
| 2025-06-10 | JPMorgan Chase & Co.Unternehmen | 234,40k | 4,78M | Kauf | 20,40 | 883,08k | 36,14% |
| 2025-06-10 | JPMorgan Chase & Co.Unternehmen | -293,45k | 5,99M | Verkauf | 20,40 | 883,08k | -24,94% |
| 2025-06-10 | 55I, LLCUnternehmen | -13,00 | 265,25 | Verkauf | 20,40 | 13,00 | -50,00% |
| 2025-06-11 | Mr. Titus B. BallVP & CAO | -134,00 | 34,62k | Verkauf | 258,36 | 0,00 | -100,00% |
| 2025-06-10 | Dr. Xiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | -41,76k | 10,70M | Derivative Exercise and Sale | 6,50 - 264,85 | 0,00 | - |
| 2025-06-10 | Mr. Qingqing YiIndependent Non-Executive Director and Member of Scientific Advisory Committee | -29,61k | 0,00 | Other Disposition | - | - | - |
| 2025-06-09 | JP Morgan Asset ManagementUnternehmen | -8,10k | 166,22k | Verkauf | 20,52 | 117,50k | -6,45% |
| 2025-06-09 | JPMorgan Chase & Co.Unternehmen | 33,24k | 682,15k | Kauf | 20,52 | 305,52k | 12,21% |
| 2025-06-09 | JPMorgan Chase & Co.Unternehmen | -32,45k | 0,00 | Other Disposition | - | 305,52k | -9,60% |
| 2025-06-09 | JPMorgan Chase & Co.Unternehmen | 834,32k | 17,12M | Kauf | 20,52 | 941,77k | 776,41% |
| 2025-06-09 | JPMorgan Chase & Co.Unternehmen | -841,00k | 0,00 | Other Disposition | - | 941,77k | -47,17% |
| 2025-06-06 | JP Morgan Asset ManagementUnternehmen | 65,00 | 1,28k | Kauf | 19,64 | 253,51k | 0,03% |
| 2025-06-06 | JPMorgan Chase & Co.Unternehmen | 30,99k | 608,52k | Kauf | 19,64 | 304,73k | 11,32% |
| 2025-06-06 | JPMorgan Chase & Co.Unternehmen | -7,15k | 140,41k | Verkauf | 19,64 | 304,73k | -2,29% |
| 2025-06-06 | JPMorgan Chase & Co.Unternehmen | 215,30k | 4,23M | Kauf | 19,64 | 948,46k | 29,37% |
| 2025-06-06 | JPMorgan Chase & Co.Unternehmen | -982,27k | 19,29M | Verkauf | 19,64 | 948,46k | -50,88% |
| 2025-06-06 | JPMorgan Chase & Co.Unternehmen | -206,00k | 0,00 | Other Disposition | - | 948,46k | -17,84% |
| 2025-06-06 | 55I, LLCUnternehmen | 13,00 | 255,29 | Kauf | 19,64 | 26,00 | 100,00% |
| 2025-06-06 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -700,00 | 179,28k | Verkauf | 255,78 - 256,79 | 0,00 | -100,00% |
| 2025-06-06 | Mr. Wang LaiPresident and Global Head of Research & Development | -1,40k | 353,85k | Verkauf | 250,71 - 255,30 | 0,00 | -100,00% |
| 2025-06-06 | Dr. Xiaobin WuInsider | -1,93k | 489,59k | Verkauf | 250,74 - 255,77 | 16,37k | -10,57% |
| 2025-06-06 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -5,13k | 1,30M | Verkauf | 250,84 - 255,74 | 0,00 | -100,00% |
| 2025-06-05 | JPMorgan Chase & Co.Unternehmen | 372,47k | 7,35M | Kauf | 19,73 | 936,72k | 66,01% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
